Humoral Responses After SARS-CoV-2 mRNA Vaccination and Breakthrough Infection in Cancer Patients.
Mayo Clin Proc Innov Qual Outcomes
; 6(2): 120-125, 2022 Apr.
Article
in En
| MEDLINE
| ID: mdl-34926993
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Mayo Clin Proc Innov Qual Outcomes
Year:
2022
Document type:
Article